Loading
Latest filing published 13 Mar 2018 for 9 METERS BIOPHARMA, INC..
Not enough history yet: 0 closed purchases, at least 2 are needed.
David H. Clarke discloses dealings in 3 companies, chiefly 9 Meters Biopharma, Inc., Omega Protein Corp and Jacuzzi Brands Inc. Over a trading history stretching from 30 September 2006 to 26 January 2018, the count stands at 14 filings.
No open-market sale appears; the market trades are 5 purchases worth €472k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 8 share grants. 2018 to date brings 5 purchases and no sales.
A typical purchase (the median) is worth €90k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.
Most recently, on 13 March 2018, the filings show an open-market purchase worth €85k in 9 Meters Biopharma, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 13 declarations